TiO₂ nanotubes promote osteogenic differentiation of human bone marrow stem cells via epigenetic regulation of RMRP/DLEU2/EZH2 pathway

Abstract

TiO2 nanotubes (TNTs) significantly promote osteogenic differentiation and bone regeneration of cells. Nevertheless, the biological processes by which they promote osteogenesis are currently poorly understood. Long non-coding RNAs (lncRNAs) are essential for controlling osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Epigenetic chromatin modification is one of the pathways in which lncRNAs regulate osteogenic differentiation. Here, we reported that TNTs could upregulate lncRNA RMRP, and inhibition of lncRNA RMRP in human bone marrow mesenchymal stem cells (hBMSCs) grown on TNTs could decrease runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN) expression. Furthermore, we discovered that inhibiting lncRNA RMRP elevated the expression of lncRNA DLEU2, and lncRNA DLEU2 knockdown promoted osteogenic differentiation in hBMSCs. RNA immunoprecipitation (RIP) experiments showed that lncRNA DLEU2 could interact with EZH2 to induce H3K27 methylation in the promoter regions of RUNX2 and OCN, suppressing gene expression epigenetically. According to these results, lncRNA RMRP is upregulated by TNTs to promote osteogenic differentiation through DLEU2/EZH2-mediated epigenetic modifications.